The epidemiology of anal human papillomavirus infection among women and men having sex with women

Sexual Health

Volumn 9, Issue 6, 2012, Pages 538-546

  Nyitray, Alan G ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

anal sex; cancer; genital warts; heterosexual; HPV; review.

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VIRUS DNA; WART VIRUS VACCINE;

ANUS INFECTION; ANUS INTERCOURSE; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; DRUG EFFICACY; FEMALE; GENOTYPE; GRAFT RECIPIENT; GRAFT REJECTION; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; INTESTINE INFECTION; LESBIAN; MALE; MALE HOMOSEXUAL; MIXED INFECTION; ORGAN TRANSPLANTATION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; SEXUAL BEHAVIOR; SMOKING; SYSTEMATIC REVIEW; VIRAL CLEARANCE; WART VIRUS;

ADULT; ANAL CANAL; ANUS DISEASES; FEMALE; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEX DISTRIBUTION; SEXUALITY; UNSAFE SEX;

EID: 84870406988     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH12021     Document Type: Article

References (52)

1. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIVinfected persons in the absence of anal intercourse. Ann Intern Med 2003; 138(6): 453-9.
2. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004; 190(9): 1685-91. doi:10.1086/424599
3. Park IU, Ogilvie JW, Anderson KE, Li ZZ, Darrah L, Madoff R, et al. Anal human papillomavirus infection and abnormal anal cytology in women with genital neoplasia. Gynecol Oncol 2009; 114(3): 399-403. doi:10.1016/j.ygyno.2009.05.008
4. Kojic EM, Cu-Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study). Sex Transm Dis 2011; 38(4): 253-9.
5. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIVnegative women. J Infect Dis 2001; 183(3): 383-91. doi:10.1086/ 318071
6. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83(2): 205-11.
7. Nyitray A, Nielson CM, Harris RB, Flores R, Abrahamsen M, Dunne EF, et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis 2008; 197(12): 1676-84. doi:10.1086/588145
8. Leung WY, Chan PKS, Lau KH, Ho KM. The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics in Hong Kong. Hong Kong J Dermatol Venereol 2011; 19(1): 6-13.
9. Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, et al. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol 2011; 12(9): 862-70. doi:10.1016/S1470-2045(11)70213-3
10. Hernandez BY, McDuffie K, Zhu X, Wilkens LR, Killeen J, Kessel B, et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005; 14(11): 2550-6. doi:10.1158/1055-9965.EPI-05-0460
11. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort Study. J Infect Dis 2008; 197(7): 957-66. doi:10.1086/529207
12. Hillemanns P, Ellerbrock TV, McPhillips S, Dole P, Alperstein S, Johnson D, et al. Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 1996; 10(14): 1641-7.
13. Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TA, et al. Anal intraepithelial neoplasia in a multisite study of HIVinfected and high-risk HIV-uninfected women. AIDS 2009; 23(1): 59-70. doi:10.1097/QAD. 0b013e32831cc101
14. Crawford R, Grignon AL, Kitson S, Winder DM, Ball SLR, Vaughan K, et al. High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer 2011; 11: 473.doi:10.1186/ 1471-2407-11-473
15. Valari O, Koliopoulos G, Karakitsos P, Valasoulis G, Founta C, Godevenos D, et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol. 2011; 122: 505-508. doi:10.1016/j.ygyno.2011.05.033
16. Moscicki AB, Durako SJ, Houser J, Ma Y, Murphy DA, Darragh TM, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003; 17(3): 311-20. doi:10.1097/00002030- 200302140-00004
17. Law CL, Thompson CH, Rose BR, Cossart YE. Anal intercourse: a risk factor for anal papillomavirus infection in women? Genitourin Med 1991; 67(6): 464-8.
18. Palefsky J. Biology of HPV in HIV infection. Adv Dent Res 2006; 19(1): 99-105. doi:10.1177/154407370601900120
19. Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 2003; 12(7): 638-42.
20. Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202(10): 1567-76. doi:10.1086/656775
21. Tandon R, Baranoski AS, Huang F, de las Morenas A, Vragovic O, Sullivan M, et al. Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol. 2010; 203(1): 21e1-6. doi:10.1016/j.ajog.2010. 01.010
22. Gonçalves MA, Randi G, Arslan A, Villa LL, Burattini MN, Franceschi S, et al. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008; 3: 5. doi:10.1186/1750-9378-3-5
23. Shvetsov YB, Hernandez BY, McDuffie K, Wilkens LR, Zhu XM, Ning L, et al. Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV Cohort Study. Clin Infect Dis 2009; 48(5): 536-46. doi:10.1086/596758
24. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010; 201(9): 1331-9. doi:10.1086/651620
25. de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011; 52(9): 1174-81. doi:10.1093/cid/cir064
26. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12(5): 495-503. doi:10.1097/00002030-1998050 00-00011
27. Goodman MT, McDuffie K, Hernandez BY, Wilkens LR, Zhu X, Thompson PJ, et al. The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2011; 203 (3): 335-40. doi:10.1093/infdis/jiq058
28. Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14(6): 888-94. doi:10.3201/eid1406.070616.2
29. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101(2): 270-80. doi:10.1002/cncr.20365
30. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93(11): 843-9. doi:10.1093/jnci/93.11.843
31. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Lu B, Smith D, Abrahamsen M, et al. Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV In Men (HIM) Study. J Infect Dis 2011; 203(1): 49-57. doi:10.1093/infdis/jiq021
32. Burchell AN, Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163(6): 534-43. doi:10.1093/aje/ kwj077
33. Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196(8): 1128-36. doi:10.1086/521192
34. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect 1999; 75(5): 317-9. doi:10.1136/sti.75.5.317
35. Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999; 8(2): 173-8.
36. Shvetsov YB, Hernandez BY, Wilkens LR, Thompson PJ, Franke AA, Zhu XM, et al. Plasma micronutrients and the acquisition and clearance of anal human papillomavirus infection: the Hawaii HPV Cohort Study. Cancer Res 2010; 70(23): 9787-97. doi:10.1158/0008- 5472.CAN-10-1374
37. Nicolau SM, Camargo CG, Stavale JN, Castelo A, Dores GB, Lorincz A, et al. Human papillomavirusDNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005; 65(2): 251-5. doi:10.1016/j.urology.2004.09.031
38. Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourinary Medicine 1994; 70(4): 240-6.
39. Nyitray AG, Smith D, Villa L, Lazcano-Ponce E, Abrahamsen M, Papenfuss M, et al. Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a crossnational study. J Infect Dis 2010; 201(10): 1498-508. doi:10.1086/ 652187
40. Yu CT, Chao SC, Lee HC, Chou CY, Ko WC, Liu HY, et al. High prevalence of anal human papillomavirus infection and associated risky behaviors in men infected with human immunodeficiency virus in Taiwan. AIDS Behav 2012. doi:10.1007/s10461-012-0173-6
41. Sirera G, Videla S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, et al. High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006; 20(8): 1201-4. doi:10.1097/01.aids. 0000226963.10342.f4
42. Nyitray AG, Carvalho da Silva RJ, Baggio ML, Smith D, Abrahamsen M, Papenfuss M, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV In Men Study. J Infect Dis 2011; 204(11): 1711-22. doi:10.1093/infdis/jir637
43. Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46(4): S20-6. doi:10.1016/j.jadohealth.2010.01.016
44. Giuliano AR, Lazcano E, Villa LL, Flores R, Salmeron J, Lee JH, et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer 2009; 124(6): 1251-7. doi:10.1002/ijc.24097
45. Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86(5): 705-11. doi:10.1038/sj.bjc.6600194
46. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, Cruz-Valdez A, Diaz V, Schiavon R, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006; 119(8): 1934-9. doi:10.1002/ijc.21992
47. Ferenczy A, Bergeron C, Richart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989; 74(6): 950-4.
48. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365(17): 1576-85. doi:10.1056/NEJMoa1010971
49. Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377(9769): 932-40. doi:10.1016/S0140-6736(10)62342- 2
50. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Muhlbacher F, Salat A. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004; 17(7): 366-9. doi:10.1111/j.1432-2277.2004. tb00456.x
51. Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81(3): 365-7. doi:10.1002/bjs.1800810313
52. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11(1): 39-44. doi:10.1016/S1473-3099(10) 70225-5